Future Impact of mRNA Therapy on Cardiovascular Diseases.
- Published in:
- Methodist DeBakey Cardiovascular Journal, 2022, v. 18, n. 5, p. 64, doi. 10.14797/mdcvj.1169
- By:
- Publication type:
- Article
Works matching IS 19476094 AND DT 2022 AND VI 18 AND IP 5
Results: 13
1
2
Cardiovascular Pharmacology: Contemporary Physiologic and Scientific Approaches to Cardiovascular Disease Prevention and Treatment.
- Published in:
- Methodist DeBakey Cardiovascular Journal, 2022, v. 18, n. 5, p. 1, doi. 10.14797/mdcvj.1184
- By:
- Publication type:
- Article
3
Expanding the Legacy: The National Library of Medicine Michael E. DeBakey Lecture in the History of Medicine.
- Published in:
- Methodist DeBakey Cardiovascular Journal, 2022, v. 18, n. 5, p. 87, doi. 10.14797/mdcvj.1154
- By:
- Publication type:
- Article
4
Ventricular Septal Rupture Complicating Silent Myocardial Infarction.
- Published in:
- Methodist DeBakey Cardiovascular Journal, 2022, v. 18, n. 5, p. 77, doi. 10.14797/mdcvj.1168
- By:
- Publication type:
- Article
5
End of the Day.
- Published in:
- 2022
- By:
- Publication type:
- Image
6
Opportunities for Earlier Diagnosis and Treatment of Cardiac Amyloidosis.
- Published in:
- Methodist DeBakey Cardiovascular Journal, 2022, v. 18, n. 5, p. 27, doi. 10.14797/mdcvj.1163
- By:
- Publication type:
- Article
7
Glucocentric Drugs in Cardiovascular Disease Protection and Heart Failure.
- Published in:
- Methodist DeBakey Cardiovascular Journal, 2022, v. 18, n. 5, p. 40, doi. 10.14797/mdcvj.1155
- By:
- Publication type:
- Article
8
How a New Understanding of Drug or Drug Class Pharmacology Often Drives Drug Development: A Conversation with Steven E. Nissen, MD.
- Published in:
- Methodist DeBakey Cardiovascular Journal, 2022, v. 18, n. 5, p. 54, doi. 10.14797/mdcvj.1181
- By:
- Publication type:
- Article
9
Constantly Bombarded with New Drugs: What’s a Cardiologist to Do?
- Published in:
- Methodist DeBakey Cardiovascular Journal, 2022, v. 18, n. 5, p. 74, doi. 10.14797/mdcvj.1179
- By:
- Publication type:
- Article
10
The Noncompliant Patient.
- Published in:
- Methodist DeBakey Cardiovascular Journal, 2022, v. 18, n. 5, p. 81, doi. 10.14797/mdcvj.1166
- By:
- Publication type:
- Article
11
Pharmacotherapy for Essential Hypertension: A Brief Review.
- Published in:
- Methodist DeBakey Cardiovascular Journal, 2022, v. 18, n. 5, p. 5, doi. 10.14797/mdcvj.1175
- By:
- Publication type:
- Article
12
Medical Therapy for Heart Failure with Preserved Ejection Fraction.
- Published in:
- Methodist DeBakey Cardiovascular Journal, 2022, v. 18, n. 5, p. 17, doi. 10.14797/mdcvj.1162
- By:
- Publication type:
- Article
13
The Future of Antiarrhythmic Drug Therapy: Will Drugs Be Entirely Replaced by Procedures?
- Published in:
- Methodist DeBakey Cardiovascular Journal, 2022, v. 18, n. 5, p. 58, doi. 10.14797/mdcvj.1185
- By:
- Publication type:
- Article